Selected skin involvement of necrobiosis lipoidica type and skin and mucous membrane fungal infections in diabetes mellitus

Česká verzia

Authors: doc. MUDr. Miloslav Salavec, CSc.; Marie Šimková
Authors place of work: Klinika nemocí kožních a pohlavních LF UK a FN Hradec Králové, přednosta doc. MUDr. Karel Ettler, CSc.
Published in the journal: Vnitř Lék 2015; 61(6): 592-596
Category:

Předneseno na mezioborovém sympoziu s postgraduálním zaměřením „Diabetik – společný pacient diabetologa a ortopeda“ 10. října 2014 v Hradci Králové.

Summary

Article reviews some skin and mucosal lesions associated with diabetes mellitus with focus on skin fungal infections and necrobiosis lipoidica.

Key words:
diabetes mellitus – necrobiosis lipoidica – skin and mucous membrane fungal infections in diabetes mellitus – skin involvement

Zdroje

1. Arenberger P. Kožní projevy u interních chorob – diabetes mellitus. Ref výb dermatovenerologie 2008; 50(1): 72–75.

2. Barnes CJ, Davis L. Necrobiosis lipoidica. 2012. Updated 2014. Dostupné z HTTP: <http://emedicine.medscape.com/article/1103467-overview>.

3. Beattie PE, Dawe RS, Ibbotson SH et al. UVA1 phototherapy for treatment of necrobiosis lipoidica. Clin Exp Dermatol 2006; 31(2): 235–238.

4. Boyd AS. Treatment of necrobiosis lipoidica with pioglitazone. J Am Acad Dermatol 2007; 57(5 Suppl): S120-S121.

5. Clayton TH, Harrison PV. Successful treatment of chronic ulcerated necrobiosis lipoidica with 0.1% topical tacrolimus ointment. Br J Dermatol 2005; 152(3): 581–582.

6. De Rie MA, Sommer A, Hoekzema R et al. Treatment of necrobiosis lipoidica with topical psoralen plus ultraviolet A. Br J Dermatol 2002; 147(4): 743–747.

7. Durupt F, Dalle S, Debarbieux S et al. Successful treatment of necrobiosis lipoidica with antimalarial agents. Arch Dermatol 2008; 144(1): 118–119.

8. Eldor A, Diaz EG, Naparstek E. Treatment of diabetic necrobiosis with aspirin and dipyridamole. N Engl J Med 1978; 298(18): 1033.

9. Handfield-Jones S, Jones S, Peachey R High dose nicotinamide in the treatment of necrobiosis lipoidica. Br J Dermatol 1988; 118(5): 693–696.

10. Heidenheim M, Jemec GB. Successful treatment of necrobiosis lipoidica diabeticorum with photodynamic therapy. Arch Dermatol 2006; 142(12): 1548–1550.

11. Kolde G, Muche JM, Schulze P et al. Infliximab: a promising new treatment option for ulcerated necrobiosis lipoidica. Dermatology 2003; 206(2): 180–181.

12. Kukreja T, Petersen J. Thalidomide for the treatment of refractory necrobiosis lipoidica. Arch Dermatol 2006; 142(1): 20–22.

13. Lim C, Tschuchnigg M, Lim J. Squamous cell carcinoma arising in an area of long-standing necrobiosis lipoidica. J Cutan Pathol 2006; 33(8): 581–583.

14. Littler CM, Tschen EH. Pentoxifylline for necrobiosis lipoidica diabeticorum. J Am Acad Dermatol 1987; 17(2 Pt 1): 314–316.

15. Marr TJ, Traisman HS, Griffith BH et al. Necrobiosis lipoidica diabeticorum in a juvenile diabetic: treatment by excision and skin grafting. Cutis 1977; 19(3): 348–350.

16. Mensing H. Clofazimine – therapeutic alternative in necrobiosis lipoidica and granuloma anulare. Hautarzt 1989; 40(2): 99–103.

17. Miller RA. The Koebner phenomenon. Int J Dermatol 1982; 21(4): 192–197.

18. Moreno-Arias GA, Camps-Fresneda A. Necrobiosis lipoidica diabeticorum treated with the pulsed dye laser. J Cosmet Laser Ther 2001; 3(3): 143–146.

19. Rhodes EL. Necrobiosis lipoidica treated with ticlopidine. Acta Derm Venereol 1986; 66(5): 458.

20. Skořepová M. Mykózy a diabetes. Vnitř Lék 2006; 52(5): 470–473.

21. Spenceri EA, Nahass GT. Topically applied bovine collagen in the treatment of ulcerative necrobiosis lipoidica diabeticorum. Arch Dermatol 1997; 133(7): 817–818.

22. Ullman S, Dahl MV. Necrobiosis lipoidica. An immunofluorescence study. Arch Dermatol 1977; 113(12): 1671–1673.

23. Zhang KS, Quan LT, Hsu S. Treatment of necrobiosis lipoidica with etanercept and adalimumab. Dermatol Online J 2009; 15(12): 12.